Proponents say using the technology to expand care access in skilled nursing facilities (SNFs) could significantly reduce hospital admissions from by permitting Medicare to enter into value-based care arrangements with medical groups to provide care via telemedicine consultations.
Acute care providers get a payment increase from Medicare of 3% and long-term care hospitals receive an update of 1.35% in a final rule issued Thursday by the Centers for Medicare and Medicaid Services (CMS).
An international panel of 11 clinical and research experts from around the world reviewed the most current pharmacological and non-pharmacological treatment recommendations for these symptoms in people with Alzheimer’s disease.
A tight labor market has continued to drive up construction costs for skilled nursing facilities — and that’s before accounting for the potential effects of disruptive new tariffs from the Trump administration.
The report calls for the Centers for Medicare and Medicaid Services, which is a key player in the funding of hospice services, to increase its level of scrutiny to improve the detection of these problems.
Greystone is joining forces with senior living developer and operator Lake Gibson Village to meet a community need for effective post-acute care services for its residents within their continuum of care.
Less than a month after a New York Times story revealed concerns about insufficient nursing home staffing levels, the Centers for Medicare & Medicaid Services (CMS) handed out nearly 1,400 one-star reviews.
A Raleigh start-up that has created an AI-based system to collect data and offer advice on the treatment of early-stage Alzheimer’s disease says it’s now working to expand the number of clinics it works with.
The portal for the National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (NIAGADS) is currently undergoing beta testing involving a small number of investigators, with broader access slated to begin next month.
Though mental decline can be an uncomfortable topic for patients and their doctors, the panel says family physicians should do a thorough evaluation when concerning symptoms arise and share the diagnosis candidly.
A new report from top researchers says the number of drugs advancing through clinical phase two and phase three trials provides reason to believe that breakthroughs may be in the current pharmaceutical pipeline.